Literature DB >> 12438469

The apolipoprotein E epsilon 2 allele and decline in episodic memory.

R S Wilson1, J L Bienias, E Berry-Kravis, D A Evans, D A Bennett.   

Abstract

OBJECTIVES: The apolipoprotein E (apoE) epsilon 4 allele is related to decline in multiple cognitive domains, especially episodic memory, but the effect of the epsilon 2 allele on change in different forms of cognitive function has been difficult to establish.
METHODS: Participants are from the Religious Orders Study. At baseline, they were at least 65 years old and free of clinical evidence of dementia. For up to eight years, they underwent annual clinical evaluations that included detailed cognitive function assessment from which previously established summary measures of episodic memory, semantic memory, working memory, perceptual speed, and visuospatial ability were derived. Growth curve models were used to assess change in each measure and its relation to apoE genotype, controlling for age, sex, education, and baseline level of cognition. Follow up data were available in 669 persons (98% of those eligible). We treated those with the epsilon 3/3 genotype as the reference group (n=425), which was contrasted with epsilon 2 ( epsilon 2/2, epsilon 2/3; n=86), and epsilon 4 ( epsilon 3/4, epsilon 4/4; n=158) subgroups.
RESULTS: Rate of episodic memory change in the three subgroups significantly differed, with an average annual increase of 0.016 units in the epsilon 2 subgroup and annual decreases of 0.022 units in those with epsilon 3/3 and of 0.073 units in the epsilon 4 subgroup. The epsilon 2 subgroup did not differ from those with epsilon 3/3 in rate of decline in other cognitive systems. The epsilon 4 subgroup declined more rapidly than those with epsilon 3/3 in semantic memory and perceptual speed but not in working memory or visuospatial ability.
CONCLUSION: Possession of one or more apoE epsilon 2 alleles is associated with reduced decline in episodic memory in older persons.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12438469      PMCID: PMC1757351          DOI: 10.1136/jnnp.73.6.672

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  27 in total

1.  Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E.

Authors:  R Mayeux; S A Small; M Tang; B Tycko; Y Stern
Journal:  Neurobiol Aging       Date:  2001 Jul-Aug       Impact factor: 4.673

2.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

3.  Random-effects models for longitudinal data.

Authors:  N M Laird; J H Ware
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

4.  Apolipoprotein E genotypes and cognitive functions in healthy elderly persons.

Authors:  H B Staehelin; P Perrig-Chiello; C Mitrache; A R Miserez; W J Perrig
Journal:  Acta Neurol Scand       Date:  1999-07       Impact factor: 3.209

5.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

6.  Natural history of mild cognitive impairment in older persons.

Authors:  D A Bennett; R S Wilson; J A Schneider; D A Evans; L A Beckett; N T Aggarwal; L L Barnes; J H Fox; J Bach
Journal:  Neurology       Date:  2002-07-23       Impact factor: 9.910

7.  Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms.

Authors:  J M Ordovas; L Litwack-Klein; P W Wilson; M M Schaefer; E J Schaefer
Journal:  J Lipid Res       Date:  1987-04       Impact factor: 5.922

8.  The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period.

Authors:  Robert S Wilson; Julie A Schneider; Lisa L Barnes; Laurel A Beckett; Neelum T Aggarwal; Elizabeth J Cochran; Elizabeth Berry-Kravis; Julie Bach; Jacob H Fox; Denis A Evans; David A Bennett
Journal:  Arch Neurol       Date:  2002-07

9.  Progression of gait disorder and rigidity and risk of death in older persons.

Authors:  R S Wilson; J A Schneider; L A Beckett; D A Evans; D A Bennett
Journal:  Neurology       Date:  2002-06-25       Impact factor: 9.910

10.  Individual differences in rates of change in cognitive abilities of older persons.

Authors:  Robert S Wilson; Laurel A Beckett; Lisa L Barnes; Julie A Schneider; Julie Bach; Denis A Evans; David A Bennett
Journal:  Psychol Aging       Date:  2002-06
View more
  61 in total

1.  Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects.

Authors:  G C Chiang; P S Insel; D Tosun; N Schuff; D Truran-Sacrey; S T Raptentsetsang; C R Jack; P S Aisen; R C Petersen; M W Weiner
Journal:  Neurology       Date:  2010-10-27       Impact factor: 9.910

2.  Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry study.

Authors:  Po H Lu; Paul M Thompson; Alex Leow; Grace J Lee; Agatha Lee; Igor Yanovsky; Neelroop Parikshak; Theresa Khoo; Stephanie Wu; Daniel Geschwind; George Bartzokis
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

3.  Genetic and vascular modifiers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension.

Authors:  Naftali Raz; Karen M Rodrigue; Kristen M Kennedy; Susan Land
Journal:  Neuropsychology       Date:  2009-01       Impact factor: 3.295

4.  Cognitive decline impairs financial and health literacy among community-based older persons without dementia.

Authors:  Patricia A Boyle; Lei Yu; Robert S Wilson; Eisuke Segawa; Aron S Buchman; David A Bennett
Journal:  Psychol Aging       Date:  2013-08-19

5.  Rhinal hypometabolism on FDG PET in healthy APO-E4 carriers: impact on memory function and metabolic networks.

Authors:  Mira Didic; Olivier Felician; Natalina Gour; Rafaelle Bernard; Christophe Pécheux; Olivier Mundler; Mathieu Ceccaldi; Eric Guedj
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-04-22       Impact factor: 9.236

6.  Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories.

Authors:  Brian J Lopresti; Elizabeth M Campbell; Zheming Yu; Stewart J Anderson; Ann D Cohen; Davneet S Minhas; Beth E Snitz; Sarah K Royse; Carl R Becker; Howard J Aizenstein; Chester A Mathis; Oscar L Lopez; William E Klunk; Dana L Tudorascu
Journal:  Neurobiol Aging       Date:  2020-05-31       Impact factor: 4.673

7.  An International Evaluation of Cognitive Reserve and Memory Changes in Early Old Age in 10 European Countries.

Authors:  Dorina Cadar; Annie Robitaille; Sean Clouston; Scott M Hofer; Andrea M Piccinin; Graciela Muniz-Terrera
Journal:  Neuroepidemiology       Date:  2017-02-21       Impact factor: 3.282

8.  Apolipoprotein E ε2 and functional decline in amnestic mild cognitive impairment and Alzheimer disease.

Authors:  Aaron Bonner-Jackson; Ozioma Okonkwo; Geoffrey Tremont
Journal:  Am J Geriatr Psychiatry       Date:  2012-07       Impact factor: 4.105

Review 9.  Use of genetic variation as biomarkers for Alzheimer's disease.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

10.  Association Between APOE Alleles and Change of Neuropsychological Tests in the Long Life Family Study.

Authors:  Mengtian Du; Stacy L Andersen; Nicole Schupf; Mary F Feitosa; Megan S Barker; Thomas T Perls; Paola Sebastiani
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.